Neuropathy - peripheral in Pantoprazole - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Neuropathy - peripheral, when it was recovered, drug effectiveness, race, and more among people who take Pantoprazole (pantoprazole sodium). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,159 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Neuropathy - peripheral?

Neuropathy - peripheral (surface nerve damage) is found to be associated with 804 drugs and 1,005 conditions by eHealthMe. Check the latest studies of Neuropathy - peripheral.



On Apr, 06, 2026

51 people who have Neuropathy - peripheral while taking Pantoprazole were studied.

Could Pantoprazole cause Neuropathy - peripheral?

Severity of Neuropathy - peripheral *:

  • least: 13.64 %
  • moderate: 47.73 %
  • severe: 31.82 %
  • most severe: 6.82 %

When people recovered from Neuropathy - peripheral *:

  • while on drug: 0.0 %
  • after off the drug: 8.33 %
  • not yet: 91.67 %

Effectiveness of Pantoprazole *:

  • not at all: 0.0 %
  • somewhat: 8.82 %
  • moderate: 20.59 %
  • high: 58.82 %
  • very high: 11.76 %

Race of the people *:

  • African American, Non-Hispanic: 0.0 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 2.22 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 4.44 %
  • White, Non-Hispanic: 93.33 %

Time on Pantoprazole *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 7.69 %
  • 6 - 12 months: 15.38 %
  • 1 - 2 years: 15.38 %
  • 2 - 5 years: 35.9 %
  • 5 - 10 years: 20.51 %
  • 10+ years: 5.13 %

Gender of people when taking Pantoprazole *:

  • female: 62.75 %
  • male: 37.25 %

Age of people when taking Pantoprazole *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 3.92 %
  • 30-39: 3.92 %
  • 40-49: 17.65 %
  • 50-59: 25.49 %
  • 60+: 49.02 %

Conditions people have *:

  1. High Blood Pressure: 18 people, 35.29%
  2. High Blood Cholesterol: 13 people, 25.49%
  3. Stress And Anxiety: 12 people, 23.53%
  4. Depression: 11 people, 21.57%
  5. Diabetes: 7 people, 13.73%
  6. Pain: 6 people, 11.76%
  7. Allergies: 6 people, 11.76%
  8. Insomnia (sleeplessness): 6 people, 11.76%
  9. Constipation: 4 people, 7.84%
  10. Blood Clots: 4 people, 7.84%

Other drugs people take besides Pantoprazole *:

  1. Gabapentin: 10 people, 19.61%
  2. Vitamin D: 8 people, 15.69%
  3. Metformin: 7 people, 13.73%
  4. Losartan: 7 people, 13.73%
  5. Aspirin: 7 people, 13.73%
  6. Atorvastatin Calcium: 7 people, 13.73%
  7. Lisinopril: 6 people, 11.76%
  8. B12: 6 people, 11.76%
  9. Duloxetine Hydrochloride: 4 people, 7.84%
  10. B Complex Vitamin: 4 people, 7.84%

Other side effects people have besides Neuropathy - peripheral *:

  1. Fatigue (feeling of tiredness): 9 people, 17.65%
  2. High Blood Pressure: 8 people, 15.69%
  3. Vision Problems: 6 people, 11.76%
  4. High Blood Cholesterol: 6 people, 11.76%
  5. Stress And Anxiety: 6 people, 11.76%
  6. Joint Pain: 5 people, 9.80%
  7. Depression: 5 people, 9.80%
  8. Dizziness: 5 people, 9.80%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 7.84%
  10. Tinnitus (a ringing in the ears): 4 people, 7.84%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and have Neuropathy - peripheral?

Check whether Neuropathy - peripheral is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

How the study uses the data?

The study is based on pantoprazole sodium (the active ingredients of Pantoprazole). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: